{"id":37574,"date":"2023-01-01T00:00:00","date_gmt":"2023-01-01T00:00:00","guid":{"rendered":"https:\/\/ibima.eu\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/"},"modified":"2024-07-25T10:05:56","modified_gmt":"2024-07-25T10:05:56","slug":"management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced","status":"publish","type":"post","link":"https:\/\/ibima.eu\/es\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/","title":{"rendered":"Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-\/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 &#8211; EUROPEAN UROLOGY"},"content":{"rendered":"<span class=\"read-more-toggle\">Ver Autores<\/span><div class=\"read-more-content\" style=\"display: none;\"><p>Gillessen, Silke; Bossi, Alberto; Davis, Ian D.; de Bono, Johann; Fizazi, Karim; James, Nicholas D.; Mottet, Nicolas; Shore, Neal; Small, Eric; Smith, Mathew; Sweeney, Christopher; Tombal, Bertrand; Antonarakis, Emmanuel S.; Aparicio, Ana M.; Armstrong, Andrew J.; Attard, Gerhardt; Beer, Tomasz M.; Beltran, Himisha; Bjartell, Anders; Blanchard, Pierre; Briganti, Alberto; Bristow, Rob G.; Bulbul, Muhammad; Caffo, Orazio; Castellano, Daniel; Castro, Elena; Cheng, Heather H.; Chi, Kim N.; Chowdhury, Simon; Clarke, Caroline S.; Clarke, Noel; Daugaard, Gedske; De, Maria; Duran, Ignacio; Eeles, Ros; Efstathiou, Eleni; Efstathiou, Jason; Ekeke, Onyeanunam Ngozi; Evans, Christopher P.; Fanti, Stefano; Feng, Felix Y.; Fonteyne, Valerie; Fossati, Nicola; Frydenberg, Mark; Daniel, Vvww; Gleave, Martin; Gravis, Gwenaelle; Halabi, Susan; Heinrich, Daniel; Herrmann, Ken; Higano, Celestia; Hofmanfff, Michael S.; Horvath, Lisa G.; Hussain, Maha; Jereczek-Fossakkk, Barbara Alicja; Jonesmmm, Robert; Kanesvaran, Ravindran; Kellokumpu-Lehtinen, Pirkko-Liisa; Khauli, Raja B.; Klotz, Laurence; Kramer, Gero; Leibowitz, Raya; Logothetisp, Christopher J.; Mahal, Brandon A.; Maluf, Fernando; Mateo, Joaquin; Matheson, David; Mehra, Niven; Merseburger, Axel; Morgans, Alicia K.; Morris, Michael J.; Mrabti, Hind; Mukherji, Deborah; Murphy, Declan G.; Murthy, Vedang; Nguyen, Paul L.; Oh, William K.; Ost, Piet; O&#8217;Sullivan, Joe M.; Padhani, Anwar R.; Pezaro, Carmel; Poon, Darren M. C.; Pritchard, Colin C.; Rabah, Danny M.; Rathkopf, Dana; Reiter, Robert E.; Rubin, Mark A.; Ryan, Charles J.; Saad, Fred; Sade, Juan Pablo; Sartor, Oliver A.; Scher, Howard, I; Sharifi, Nima; Skoneczna, Iwona; Soule, Howard; Spratt, Daniel E.; Srinivas, Sandy; Sternberg, Cora N.; Steuber, Thomas; Suzuki, Hiroyoshi; Sydes, Matthew R.; Taplin, Mary-Ellen; Tilki, Derya; Turkeri, Levent; Turco, Fabio; Uemura, Hrioji; Uemura, Hirotsugu; Urun, Yuksel; Vale, Claire L.; van Oort, Inge; Vapiwala, Neha; Walz, Jochen; Yamoah, Kosj; Ye, Dingwei; Yu, Evan Y.; Zapatero, Almudena; Zilli, Thomas; Omlin, Aurelius &#8211; 2023 &#8211; 10.1016\/j.eururo.2022.11.002<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Ver AutoresGillessen, Silke; Bossi, Alberto; Davis, Ian D.; de Bono, Johann; Fizazi, Karim; James, Nicholas D.; Mottet, Nicolas; Shore, Neal; Small, Eric; Smith, Mathew; Sweeney, Christopher; Tombal, Bertrand; Antonarakis, Emmanuel S.; Aparicio, Ana M.; Armstrong, Andrew J.; Attard, Gerhardt; Beer, Tomasz M.; Beltran, Himisha; Bjartell, Anders; Blanchard, Pierre; Briganti, Alberto; Bristow, Rob G.; Bulbul, Muhammad; [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2413],"tags":[],"class_list":["post-37574","post","type-post","status-publish","format-standard","hentry","category-guias-de-practica-clinica"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-\/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 - EUROPEAN UROLOGY - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/es\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-\/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 - EUROPEAN UROLOGY - Ibima\" \/>\n<meta property=\"og:description\" content=\"Ver AutoresGillessen, Silke; Bossi, Alberto; Davis, Ian D.; de Bono, Johann; Fizazi, Karim; James, Nicholas D.; Mottet, Nicolas; Shore, Neal; Small, Eric; Smith, Mathew; Sweeney, Christopher; Tombal, Bertrand; Antonarakis, Emmanuel S.; Aparicio, Ana M.; Armstrong, Andrew J.; Attard, Gerhardt; Beer, Tomasz M.; Beltran, Himisha; Bjartell, Anders; Blanchard, Pierre; Briganti, Alberto; Bristow, Rob G.; Bulbul, Muhammad; [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/es\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-01T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-25T10:05:56+00:00\" \/>\n<meta name=\"author\" content=\"prodriguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"prodriguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\\\/\"},\"author\":{\"name\":\"prodriguez\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"headline\":\"Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-\\\/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 &#8211; EUROPEAN UROLOGY\",\"datePublished\":\"2023-01-01T00:00:00+00:00\",\"dateModified\":\"2024-07-25T10:05:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\\\/\"},\"wordCount\":318,\"commentCount\":0,\"articleSection\":[\"Guias de Practica Clinica\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\\\/\",\"name\":\"Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-\\\/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 - EUROPEAN UROLOGY - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"datePublished\":\"2023-01-01T00:00:00+00:00\",\"dateModified\":\"2024-07-25T10:05:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-\\\/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 &#8211; EUROPEAN UROLOGY\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\",\"name\":\"prodriguez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"caption\":\"prodriguez\"},\"sameAs\":[\"https:\\\/\\\/ibima.eu\"],\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/author\\\/prodriguez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-\/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 - EUROPEAN UROLOGY - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/es\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/","og_locale":"es_ES","og_type":"article","og_title":"Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-\/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 - EUROPEAN UROLOGY - Ibima","og_description":"Ver AutoresGillessen, Silke; Bossi, Alberto; Davis, Ian D.; de Bono, Johann; Fizazi, Karim; James, Nicholas D.; Mottet, Nicolas; Shore, Neal; Small, Eric; Smith, Mathew; Sweeney, Christopher; Tombal, Bertrand; Antonarakis, Emmanuel S.; Aparicio, Ana M.; Armstrong, Andrew J.; Attard, Gerhardt; Beer, Tomasz M.; Beltran, Himisha; Bjartell, Anders; Blanchard, Pierre; Briganti, Alberto; Bristow, Rob G.; Bulbul, Muhammad; [&hellip;]","og_url":"https:\/\/ibima.eu\/es\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/","og_site_name":"Ibima","article_published_time":"2023-01-01T00:00:00+00:00","article_modified_time":"2024-07-25T10:05:56+00:00","author":"prodriguez","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"prodriguez","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibima.eu\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/#article","isPartOf":{"@id":"https:\/\/ibima.eu\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/"},"author":{"name":"prodriguez","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"headline":"Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-\/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 &#8211; EUROPEAN UROLOGY","datePublished":"2023-01-01T00:00:00+00:00","dateModified":"2024-07-25T10:05:56+00:00","mainEntityOfPage":{"@id":"https:\/\/ibima.eu\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/"},"wordCount":318,"commentCount":0,"articleSection":["Guias de Practica Clinica"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ibima.eu\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ibima.eu\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/","url":"https:\/\/ibima.eu\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/","name":"Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-\/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 - EUROPEAN UROLOGY - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"datePublished":"2023-01-01T00:00:00+00:00","dateModified":"2024-07-25T10:05:56+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"breadcrumb":{"@id":"https:\/\/ibima.eu\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/management-of-patients-with-advanced-prostate-cancer-part-i-intermediate-high-risk-and-locally-advanced-disease-biochemical-relapse-and-side-effects-of-hormonal-treatment-report-of-the-advanced\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-\/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022 &#8211; EUROPEAN UROLOGY"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635","name":"prodriguez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","caption":"prodriguez"},"sameAs":["https:\/\/ibima.eu"],"url":"https:\/\/ibima.eu\/es\/author\/prodriguez\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/37574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/comments?post=37574"}],"version-history":[{"count":1,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/37574\/revisions"}],"predecessor-version":[{"id":44470,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/37574\/revisions\/44470"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/media?parent=37574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/categories?post=37574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/tags?post=37574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}